DRTS
NASDAQ HealthcareAlpha Tau Medical Ltd. - Ordinary Shares
Biotechnology
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
๐ Market Data
| Price | $13.23 |
|---|---|
| Volume | 282,833 |
| Market Cap | 1.22B |
| Beta | 1.220 |
| RSI (14-Day) | 38.9 |
| 200-Day MA | $10.57 |
| 50-Day MA | $14.29 |
| 52-Week High | $15.79 |
| 52-Week Low | $3.43 |
| Forward P/E | -24.75 |
| Price / Book | 27.74 |
๐ฏ Investment Strategy Scores
DRTS scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (80/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Over-Hyped (18/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find DRTS in your text
Paste any article, transcript, or post โ the tool will extract DRTS and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-10-29.